Skip to main content

Table 1 Three regimens for DEC administration applied in different endemic areas of bancroftian and malayan filariasis

From: Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China

Regimen

Endemic extent

Target population

Dose

Selective treatment

hypro-bancroftian filariasis

microfilaraemia positive

3.0 g DEC over 3–5 days 4.2 g DEC over 7 days

hypro- & meso- malayan filariasis

1.5–2.0 g over 2–3 days

Mass drug administration (usually combined with selective treatment)

hypro- & meso- bancroftian filariasis

>  5 years microfilaraemia-negative

3.0 g over 3–5 days

meso- & hypro- malayan filariasis

1.0–2.0 g over 2–3 days

DEC-fortified salt

meso- & hypro- bancroftian filariasis

whole population

50 mg DEC/day/person 6 consecutive months (9.0 g in total)

hypro- malayan filariasis

50 mg DEC/day/person over 3–4 consecutive months (4.5–6.0 g in total)

  1. DEC Diethylcarbamazine